Summary
The U.S. CDC's vaccine advisory panel, led by Health Secretary Robert F. Kennedy Jr., voted to limit the age for the combined MMRV vaccine to not before age 4, recommending separate shots for younger children. The panel also discussed but did not finalize decisions on hepatitis B shots for newborns and future COVID-19 vaccine guidance. The panel's recent changes and decisions may impact public confidence in vaccines.
Key Facts
- The new advisory panel voted 8-3 to limit the MMRV vaccine to children age 4 and older.
- Children under age 4 should receive separate MMR and varicella (chickenpox) vaccines.
- The decision was made due to concerns about rare febrile seizures in younger children.
- About 85% of children currently receive the vaccines separately.
- The panel delayed a decision on hepatitis B shots for newborns but may consider allowing a delay for some.
- Robert F. Kennedy Jr., previously a vaccine skeptic, appointed new members to the vaccine advisory panel.
- The CDC's panel recommendations often influence state policies and doctors' advice.
- The panel voted to keep MMRV available under the Vaccines for Children program but needs to clarify age limits with other programs.
